Clinical Trials Logo

Recurrent Enteropathy-Associated T-Cell Lymphoma clinical trials

View clinical trials related to Recurrent Enteropathy-Associated T-Cell Lymphoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT03075553 Recruiting - Clinical trials for Recurrent Adult T-Cell Leukemia/Lymphoma

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Start date: May 17, 2017
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well nivolumab works in treating patients with peripheral T-cell lymphoma that has come back after a period of improvement or that does not respond to treatment. Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells.